Brief: Anixa Biosciences Announces Opening Of Enrollment For Keytruda Arm In Ongoing Breast Cancer Vaccine Clinical Trial
07/08/2023 16:27
Aug 7 (Reuters) - Anixa Biosciences Inc ANIX.O :
* ANIXA BIOSCIENCES ANNOUNCES OPENING OF ENROLLMENT FOR
KEYTRUDA®
ARM IN ONGOING BREAST CANCER VACCINE CLINICAL TRIAL
Source text for Eikon: ID:nPn5tDb7Ya
Further company coverage: ANIX.O
Recent news on Anixa Biosciences
See all newsBrief: Anixa Biosciences Announces First Case Of Stable Disease For Three Months In Ovarian Cancer Car-T Clinical Trial
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Anixa Biosciences Inc reports results for the quarter ended July 31 - Earnings Summary
Anixa Biosciences Inc expected to post a loss of 9 cents a share - Earnings Preview
Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine